Transition from immediate-release methylphenidate (IR-MPH) to extended-release methylphenidate (OROS®-MPH, Concerta®) in Children with ADHD is associated with an improvement in functioning and quality of life – Results from a naturalistic study
| Autor: | K Niederkirchner, I Diegritz-Qaiyumi, F. Mattejat, E Kölker, B Schäuble, Ludger Hargarter |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Oros mph business.industry Methylphenidate General Medicine Naturalistic observation Quality of life (healthcare) Pediatrics Perinatology and Child Health Medicine Neurology (clinical) Immediate release Extended release business Psychiatry medicine.drug Clinical psychology |
| Zdroj: | Neuropediatrics. 39 |
| ISSN: | 1439-1899 0174-304X |
| DOI: | 10.1055/s-2008-1079586 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|